Health Services Research in Head and Neck Cancer

  • David G. Pfister
  • Hirsch S. Ruchlin
  • Elena B. Elkin
Part of the Cancer Treatment and Research book series (CTAR, volume 97)


Scientists have studied the benefits of medical interventions for centuries. With the rapid evolution and growth of social medicine in the post-World War II era, research methods developed by clinical epidemiologists, demographers, economicsts, management theorists, psychologists, and statisticians joined traditional epidemiological research in studies of the medical care field. Utilizing these techniques and those that traditionally have been used by clinicians, a new field of research evolved which is frequently called “health services research”. It is best viewed as a field not a discipline, and for the most part is population-based.[1]


Neck Cancer Neck Cancer Patient Total Laryngectomy Pneumatic Dilatation Neck Surgeon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    White KL, Frenk J, Ordonez C, Paganini JM, Starfield B. Introduction. In White KL (Ed.), Health Services Research-An Anthology. Scientific Publication No. 534. Washington, DC: Pan American Health Organization, 1992, pp. xvii–xxiv.Google Scholar
  2. 4.
    Vokes EE, Welchselbaum RR, Lippman SM, Hong NW. Head and neck cancer. N Engl J Med 1993; 328: 184–194.PubMedCrossRefGoogle Scholar
  3. 5.
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin, 1996; 65:5–27.CrossRefGoogle Scholar
  4. 7.
    Spitz NM. Epidemiology and risk factors for head and neck cancer. Sem Oncol, 1994; 21: 281–288.Google Scholar
  5. 8.
    Hussey DH, Latourette HB, Panje WR. Head and neck cancer: an analysis of the incidence, patterns of treatment, and survival at the University of Iowa. Ann Otol Rhinol Laryngol (Suppl) 1991; 152: 2–16.Google Scholar
  6. 9.
    Barra S, Barzan L, Malone A, Cadelano A, Pin M, Franceschi S, Comoretto R. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 1994; 104: 95–98.PubMedCrossRefGoogle Scholar
  7. 10.
    Brownian GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328: 159–163.CrossRefGoogle Scholar
  8. 11.
    Pelczar BT, Weed HG, Schuller DE, Young DC, Reilley TE. Identifying high-risk patients before head and neck oncologic surgery. Arch Otolaryngol Head Neck Surg 1993; 119: 861–864.PubMedGoogle Scholar
  9. 12.
    Hussain M, Kish JA, Crane L, Uwayda A, Cummings G, Ensley JF, Tapazoglou E, Al-Sarraf M. The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy. Cancer, 1991; 67: 716–721.PubMedCrossRefGoogle Scholar
  10. 13.
    Joeanson DE. Are health-care reimbursement policies a barrier to acute and cancer pain management? J Pain Symptom Manag 1994; 9: 244–253.CrossRefGoogle Scholar
  11. 14.
    Hagen PC, Nuss DW, Ellis M, Lyons GD. Health care crisis: the head and neck cancer patient and affordable health insurance. ENT J 1993; 72: 334–340.Google Scholar
  12. 15.
    Cowan DH. The effect of Medicare reimbursement policies on the cost and setting of cancer chemotherapy. Cancer Invest 1996; 14: 184–186.PubMedGoogle Scholar
  13. 16.
    Berkman BJ, Sampson SE. Psychosocial effects of cancer economics on patients and their families. Cancer 1993; 72: 2846–2849.PubMedCrossRefGoogle Scholar
  14. 17.
    Mortenson LE. Health care policies affecting the treatment of patients with cancer and cancer research. Cancer 1994: 74: 2204–2207.PubMedCrossRefGoogle Scholar
  15. 18.
    Lee K, Strauss M. Head and neck cancer in blacks. J Natl Med Assoc 1994; 86: 530–534.PubMedGoogle Scholar
  16. 19.
    Underwood SM. Enhancing the delivery of care to the disadvantaged. Cancer 1995; 3: 31–36.Google Scholar
  17. 20.
    Glynn TJ, Manley MW, Cullen JW, Mayer WJ. Cancer prevention through physician intervention. Sem Oncol 1990; 17: 391–401.Google Scholar
  18. 21.
    Young RC. Cancer prevention. Arch Otolaryngol Head Neck Surg, 1993; 119: 732–734.PubMedGoogle Scholar
  19. 22.
    Prout MN, Morris SJ, Witzburg RA, Hurley C, Chattejee S. A multidisciplinary educational program to promote head and neck cancer screening. J Cancer Educ 1992; 7:139–146.PubMedCrossRefGoogle Scholar
  20. 23.
    Talamini R, Barzan L, Franceschi S, Caruso G, Gasparin A, Comoretto R. Determinants of compliance with an early detection programm for cancer of the head and neck in northeastern Italy. Oral Oncol Eur J Cancer 1994; 30B: 415–418.CrossRefGoogle Scholar
  21. 24.
    Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJC, Wong AX, Belin TR, Calcaterra T, Robbins KT, Chonkich G, Beumer J, Ward PH. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993; 2:261–270.PubMedGoogle Scholar
  22. 25.
    Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795–801.PubMedCrossRefGoogle Scholar
  23. 26.
    Mor V, Masterson-Allen S, Houts P, Siegel K. The changing needs of patients with cancer at home. Cancer 1992; 69: 829–838.PubMedCrossRefGoogle Scholar
  24. 27.
    Guadagnoli E, Mor V. Daily living needs of cancer outpatients. J Commun Health, 1991; 16: 37–47.CrossRefGoogle Scholar
  25. 28.
    Mor V, Guadagnoli E, Wool M. An examination of the concrete service needs of advanced cancer patients. J Psychosocial Oncol 1987; 5: 1–17.CrossRefGoogle Scholar
  26. 29.
    Hileman JW, Lackey NR, Hassanein RS. Identifying the needs of home caregivers of patients with cancer. Oncol Nursing Forum 1992; 19:771–777.Google Scholar
  27. 30.
    Dropkin MJ, Malgady RG, Scott DW, Oberst MT, Strong EW. Scaling of disfigurement and dysfunction in postoperative head and neck patients. Head Neck Surg 1983; 6:559–570.PubMedCrossRefGoogle Scholar
  28. 31.
    Gamba A, Romano M, Grosso IM, Tamburini M, Cantu G, Molinari R, Ventafridda V. Psychical adjustment of patients surgically treated for head and neck cancer. Head Neck 1992; 14:218–223.PubMedCrossRefGoogle Scholar
  29. 32.
    Weymuller EA, Ahmad K, Casiano RR, Schuller D, Scott CB, Laramor,4 G, Al-Sarraf M, Jacobs JR. Surgical reporting instrument designed to improve outcome data in head and neck cancer trials. Ann Otol Rhinol Laryngol 1994; 103:499–509.PubMedGoogle Scholar
  30. 33.
    Pfister DG, Ruchlin HS. Outcome and economic issues in head and neck cancer. In Thawley S, Panje W (Eds.), Comprehensive Management of Head and Neck Tumors Edn 2. Philadelphia; Saunders 1996, in press.Google Scholar
  31. 34.
    Gotay CC, Moore TD. Assessing quality of life in head and neck cancer. Qual Life Res 1992; 1:5–17.PubMedCrossRefGoogle Scholar
  32. 35.
    Morton RP. Evolution of quality-of-life assessment in head and neck cancer. J Laryngol Otol 1995; 109:1029–1035.PubMedGoogle Scholar
  33. 36.
    Brownian GP, Levine MN, Hodson DI, Sathya J, Russell R, Skingley P, Cripps C, Eapen L, Girard A. The head and neck radiotherapy questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993; 11:863–872.Google Scholar
  34. 37.
    List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66:564–569.PubMedCrossRefGoogle Scholar
  35. 38.
    Baker C. A functional status scale for measuring quality of life outcomes in head and neck cancer patients. Cancer Nursing. 1995; 18:452–457.PubMedCrossRefGoogle Scholar
  36. 39.
    Hassan SJ, Weymuller EA Jr. Assessment of quality of life in head and neck cancer patients. Head Neck 1993; 15:485–496.PubMedCrossRefGoogle Scholar
  37. 40.
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Bamicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S IV, Thomas CR Jr., Harris J. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570–579.PubMedGoogle Scholar
  38. 41.
    Bjordal K, Kaasa S. Psychometric validation of the EORTC core quality of life questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncologica, 1992; 31:311–321.PubMedGoogle Scholar
  39. 42.
    Bjordal K, Freng A, Thorvik J, Kaasa S. Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Oral Oncol Eur J Cancer 1995; 3IB:235–241.CrossRefGoogle Scholar
  40. 43.
    D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and functional status measures in patients with head and neck cancer. Arch Otol Laryngol Head Neck Surg 1996; 122:482–487.Google Scholar
  41. 44.
    Jones E, Lund VJ, Howard DJ, Greenberg MP, McCarthy M. Quality of life of patients treated surgically for head and neck cancer. J Laryngol Otol, 1992; 106:238–242.PubMedGoogle Scholar
  42. 45.
    Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Physiol 1994; 28:847–856.CrossRefGoogle Scholar
  43. 46.
    Ground S, Zech D, Lynch J, Diefenbach C, Schug SA, Lehmann KA. Validation of World Health Organization guidelines for pain relief in head and neck cancer: a prospective study. Ann Otol Rhinol Laryngol 1993; 102:342–348.Google Scholar
  44. 47.
    Shone GR, Yardley MPJ. An audit into the incidence of handicap after unilateral radical neck dissection. J Larvngol Otol 1991; 105:760–762.Google Scholar
  45. 48.
    Suits GW, Cohen JI, Everts EC. Near-total laryngectomy: patient selection and technical considerations. Arch Otolaryngol Head Neck Surg 1996; 122:473–475.PubMedGoogle Scholar
  46. 49.
    Hoyt DJ, Lettinga JW, Leopold KA, Fisher SR. The effect of head and neck radiation therapy on voice quality. Laryngoscope 1992; 102:477–480.PubMedCrossRefGoogle Scholar
  47. 50.
    DeSanto LW, Olsen KD, Perry WC, Rohe DE, Keith RL. Quality of life after surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol, 1995; 104:763–769.PubMedGoogle Scholar
  48. 51.
    Langius A, Bjorvell H, Lind MG. Functional status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck, 1994; 16:559–568.PubMedCrossRefGoogle Scholar
  49. 52.
    Pauloski BR, Logemann JA, Rademaker AW, McConnel FMS, Stein D, Beery Q, Johson J, Heiser MA, Cardinale S, Shedd D, Graner D, Cook B, Milanti F, Collins S, Baker T. Speech and swallowing function after oral and oropharyngeal resections: one year follow-up. Head Neck, 1994; 16:313–322.PubMedCrossRefGoogle Scholar
  50. 53.
    Kreitler S, Chaitchik S, Kreitler H, Algor R. Life satisfaction and health in cancer patients, orthopedic patients and healthy individuals. Soc Sci Med 1993; 36:547–556.PubMedCrossRefGoogle Scholar
  51. 54.
    McDonough EM, Boyd JH, Varvares MA, Maves MD. Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck. Head Neck 1996; 18:269–276.PubMedCrossRefGoogle Scholar
  52. 55.
    Anthony JP, Singer MI, Deschler DG, Dougherty ET, Reed CG, Kaplan MJ. Long-term functional results after pharyngoesophageal reconstruction with the radial forearm free flap. Am J Surg 1994; 168:441–445.PubMedCrossRefGoogle Scholar
  53. 56.
    Finkler SA. The distinction between cost and charges. Ann Intern Med, 1982; 96:102–109.PubMedGoogle Scholar
  54. 57.
    Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg JM, Cohen S. Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Digest Dis Sci 1993; 38:75–85.PubMedCrossRefGoogle Scholar
  55. 58.
    Helmus C, Grin M, Westfall R. Same-day-stay head and neck surgery. Laryngoscope 1992; 102:1331–1334.PubMedCrossRefGoogle Scholar
  56. 59.
    Benninger MS, Enrique RR, Nichols RD. Symptom-directed selective endoscopy and cost containment for evaluation of head and neck cancer. Head Neck 1993; 15:532–536.PubMedCrossRefGoogle Scholar
  57. 60.
    Mittal B, Rao DV, Marks JE, Ogura JH. Comparative cost analysis of hemilaryngectomy and irradiation for early glottic carcinoma. Int J Radiat Oncol Biol Physiol 1983; 9:407–408.Google Scholar
  58. 61.
    Myers EN, Wagner RL, Johnson JT. Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol, 1994; 103:28–30.PubMedGoogle Scholar
  59. 62.
    Cragle SP, Brandenburg JH. Laser cordectomy or radiotherapy: cure rates, communication and cost. Otolaryngol Head Neck Surg, 1993; 108:648–654.PubMedGoogle Scholar
  60. 63.
    Welch WP, Miller ME, Welch GH, Fisher EX, Wennberg JE. Geographic variation in expenditures for physicians’ services in the United States. New Engl J Med 1993; 328:621–627.PubMedCrossRefGoogle Scholar
  61. 64.
    Blair EA, Johnson JT, Wagner RL, Carrau RL, Bizakis JG. Cost analysis of antibiotic prophylaxis in clean head and neck surgery. Arch Otolaryngol Head Neck Surg 1995; 121:269–271.PubMedGoogle Scholar
  62. 65.
    Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, Strong EW, Roa A, Thaler H, Polyak T, Portenoy R. Detailed quality of life assessment in patients treated with primary radiation therapy for squamous cell cancer of the base of tongue. Head Neck 1996; in press.Google Scholar
  63. 66.
    McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. New Engl J Med 1981; 305:982–987.PubMedCrossRefGoogle Scholar
  64. 68.
    Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996; 88:890–899.PubMedCrossRefGoogle Scholar
  65. 69.
    The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer, N Engl J Med 1991; 324:1685–1690.CrossRefGoogle Scholar
  66. 70.
    Brownian GP, Cronin L. Standard chemotherapy in squamous cell head and neck: what we have learned from randomized trials. Sem Oncol 1994; 21:311–319.Google Scholar
  67. 71.
    Weiss NM, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage NO neck. Arch Otolaryngol Head Neck Surg 1994; 120:699–702.PubMedGoogle Scholar
  68. 72.
    Velanovich V. Choice of treatment for stage I floor-of-mouth cancer: a decision analysis. Arch Otolaryngol Head Neck Surg, 1990; 116:951–956.PubMedGoogle Scholar
  69. 73.
    Plante DA, Piccirillo JF, Sofferman RA. Decision analysis of treatment options in pyriform sinus carcinoma. Med Decis Making 1987; 7:74–83.PubMedCrossRefGoogle Scholar
  70. 74.
    Stalpers LJA, Verbeek ALM, Van Daal WAJ. Radiotherapy or surgery for T2N0M0 glottic carcinoma? A decision-analytic approach. Radiother Oncol, 1989; 14:209–217.PubMedCrossRefGoogle Scholar
  71. 75.
    Van der Donk BJ, Levendag PC, Kupers AJ, Roest FHL, Habbema JDF, Mceuwls CA, Schmits PIM. Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: a comparison of state and process utilities. J Clin Oncol, 1995; 13:2369–2378.PubMedGoogle Scholar
  72. 76.
    Boysen M. Lovdal O, Taujo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992; 28:426–439.PubMedCrossRefGoogle Scholar
  73. 77.
    Baatenburg de Jong RJ, Knegt P, Verwoerd CDA. Reduction of the number of neck treatments in patients with head and neck cancer. Cancer 1993; 71:2312–2318.PubMedCrossRefGoogle Scholar
  74. 78.
    Shah JP. The making of a head and neck surgeon. Am J Surg 1991; 162:284–287.PubMedGoogle Scholar
  75. 79.
    Close LG, Miller RE. Head and neck surgery workforce in the year 2014. Laryngoscope 1995; 105:1081–1085.PubMedCrossRefGoogle Scholar
  76. 81.
    Bailey BJ. Restructuring the workforce in otolaryngology-head and neck surgery: it’s time to play “what if? Laryngoscope 1995; 105:1149–1151.PubMedCrossRefGoogle Scholar
  77. 82.
    Crumley RL. Survey of postgraduate fellows in otolaryngology-head and neck surgery. Arch Otolaryngol Head Neck 1994; 120:1074–1079.Google Scholar
  78. 83.
    Johnson JT, Wagner RL, Rueger RM, Goepfert H. Professional burnout among head and neck surgeons: results of a survey. Head Neck, 1993; 15:557–560.PubMedCrossRefGoogle Scholar
  79. 84.
    Schulman KA, Glick HA, Yabroff KR, Eisenberg JM. Introduction to clinical economics: assessment of cancer therapies. Monographs Natl Cancer Inst 1995; 19:1–9.Google Scholar
  80. 85.
    Bennett CL, Hillner BE, Smith TJ. Economic analysis of cancer treatment, in Abeloff M, JO Armitage, Lichter AS, Niederhuber JE (Eds.), Clinical Oncology, New York: Churchill Livingstone, 1995, pp. 187–200.Google Scholar
  81. 86.
    Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds.). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.Google Scholar
  82. 87.
    Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care, 1995; 33:828–841.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • David G. Pfister
    • 1
  • Hirsch S. Ruchlin
    • 2
  • Elena B. Elkin
    • 2
  1. 1.Memorial Sloan-Kettering Cancer CenterNew York
  2. 2.Cornell University Medical CollegeNew York

Personalised recommendations